Dr. Mohammad Jahanzeb on Neratinib and Trastuzumab in HER2-Positive Breast Cancer
November 19th 2015Mohammad Jahanzeb, MD, medical director, Sylvester Comprehensive Cancer Center at Deerfield Beach, talks about the future of treatment for patients with HER2-positive breast cancer with drugs like neratinib and trastuzumab.